Biblio Discovery — Demo Discovery Service

5 hasil untuk "Heming Zhou"

Menampilkan 1–5 · 1,01 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

    Heming Zhou; Jigang Zhang; Xue Zhang dkk.

    Signal Transduction and Targeted Therapy · 2021 · Inggris · OpenAlex Scopus

    Cancer stem cells (CSCs) show a self-renewal capacity and differentiation potential that contribute to tumor progression and therapy resistance. However, the underlying processes are still unclear. Elucidation of the key hallmarks and resistance mechanisms of CSCs may help improve patient outcomes…

  2. Artikel Jurnal

    Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy

    Yafei Wu; Jigang Zhang; Xue Zhang dkk.

    Frontiers in Pharmacology, Vol. 11 · 2020 · Inggris · DOAJ Scopus

    Cancer stem cells (CSCs) are subpopulations of cells with stem cell characteristics that produce both cancerous and non-tumorigenic cells in tumor tissues. The literature reports that CSCs are closely related to the development of hepatocellular carcinoma (HCC) and promote the malignant features of…

  3. Artikel Jurnal

    A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC

    Huihua Yang; Dahong Chen; Yafei Wu dkk.

    Cancer & Metabolism, Vol. 11 No. 1 · 2023 · Inggris · DOAJ

    Abstract Background Hepatocellular carcinoma (HCC) is a principal type of liver cancer with high incidence and mortality rates. Regorafenib is a novel oral multikinase inhibitor for second-line therapy for advanced HCC. However, resistance to regorafenib is gradually becoming a dilemma for HCC and…

  4. Artikel Jurnal

    YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer

    Henley Cheung; Huarong Chen; Danyu Chen dkk.

    Signal Transduction and Targeted Therapy, Vol. 10 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract N6-methyladenosine (m6A) modification of mRNAs is a predominant epigenetic regulatory mechanism in tumor initiation and progression. Cancer stem cells (CSCs) are the key drivers of colorectal cancer (CRC) initiation and chemotherapy resistance. Here, we found that the m6A reader YT521-B…

  5. Artikel Jurnal

    Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer

    Heming Zhou; Huarong Chen; Weixin Liu dkk.

    Nature Communications, Vol. 17 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract The role of RNA N6-methyladenoine (m6A) eraser AlkB homologue 5 (ALKBH5) in colorectal cancer (CRC) stem cells (CSCs) is unclear. Here, we find that ALKBH5 expression positively correlates with CSC markers in CRC patients. ALKBH5 induces self-renewal and stemness markers in colorectal CSCs…